Fig. 3: SFTA1P promotes cervical cancer cell metastasis in vitro and in vivo.

A, B Migration and invasion ability of CaSki and C-4 I cells transfected with SFTA1P siRNA or NC. C Wound healing assays of CaSki and C-4 I cells transfected with SFTA1P siRNA or NC. D SFTA1P promotes cervical cancer cell metastasis in vivo. Nude mice were injected intravenously with sh-scramble or sh-SFTA1P cells via the tail vein. Secondary metastatic sites were observed mainly in the pelvic cavity, followed by the lung and brain. The mice were imaged weekly for 6 weeks. Data are shown as mean ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001.